Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

October 04, 2017

FULLER v. INSYS THERAPEUTICS, INC. et al

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 28, 2022

    Claim Of Misuse Of Insys Docs Struck As Bid To 'Taint' Atty

    A New Jersey federal judge on Friday struck letters from counsel for a specialty pharmacy purporting that another lawyer misused privileged material in litigating claims related to an Insys Therapeutics opioid, finding that they were meant to "unfairly taint" that attorney and "could be deemed frivolous and sanctionable conduct."

2 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login